Health Catalyst Inc. (HCAT) PT Lowered to $7 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Sean Dodge lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $7.00 (from $9.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
